INDINAVIR ANHYDROUS

SynDRA canonical compound SYN0000957 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	CYP3A5
Mechanism of action	HIV protease inhibitor
Indication	human immunodeficiency virus (HIV-1)
Disease area	infectious disease

All known targets

indinavir
indinavir sulphate
crixivan
indinavir sulfate
Indinavir
Crixivan
IDV
Indinavir [USAN]
L-735524
Crixivan (TM)
Crixivan (TN)
L-735 524
MK-639
Propolis+Indinavir
RS-253
L-735,524
Indinavir, Sulfate (1:1)
Indinavir (*1:1 Sulfate salt*)
N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide
(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
Indinavir system suitability
9MG78X43ZT
5W6YA9PKKH
indinavir (usp-rs)
Indinavir monohydrate
INDINAVIR
indinavir system suitability (usp-rs)
Compound J
CHEBI:44032
indinavirum
RefChem:790918
DTXCID2023802
J05AE02
L735 524
L 735 524
MK 639
MK639